drugset / Trial / NCT07043283
A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase I clinical study to evaluate the pharmacokinetics (PK) similarity of single dose subcutaneous injection of Ebronucimab with different production processes in Chinese healthy male subjects.
Timeline
- Start
- 2025-10-20
- Primary completion
- 2026-02-07
- Completion
- 2026-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ebronucimab | Unknown | 150 mg | Subcutaneous |
Indications
No indication recorded.